Zürich Switzerland 2nd of June 2020 – Saiba Animal Health AG today announced the ASF-INNOVAC consortium in which it is the lead SME was ranked 1st among 378 funding applications and will thus receive funding for 3 years to research and develop a vaccine against the African Swine Fever; one of the most serious infectious …
Read MoreZürich Switzerland 2nd of October 2019 – Saiba Animal Health AG reported today that it has executed a contract with a top-tier global animal health company. Saiba Animal Health AG announced Wednesday the signing of an agreement with a major animal health company. The execution of this agreement is another important step in the companies …
Read MoreZürich Switzerland 17th of April 2019 – Saiba Animal Health AG today announced the publication of important preclinical data for their cat allergy vaccine, HypoCat™. The data were published online 17th of April 2019 in an article entitled “Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human …
Read MoreZürich Switzerland 19th of March 2019 – Saiba Animal Health AG today announced the publication of proof of principle data for a vaccine with the potential to translate into a novel therapy for osteoarthritic pain in companion animals. The data were published online 12th of March 2019 in an article entitled “Active immunisation targeting nerve …
Read MoreSaiba Animal Health AG today announced that it has been selected as a finalist to present at the prestigious Animal Health Investment Europe Forum in February 2019. The Animal Health Innovation showcase provides an opportunity for the most exciting and innovative emerging animal health companies, selected by committee, to present their breakthrough innovations and business …
Read MoreZürich Switzerland 11th of April 2018 – Saiba Animal Health AG today announced the publication of Proof of Concept data for a vaccine for treating canine atopic dermatitis (CAD) in the renowned Journal of Allergy and Clinical Immunology. The data were published online 4th of April 2018 in an article entitled “Vaccination against IL‐31 for …
Read More